Central nervous system muscle spasm pathways

The term refers to the CNS neuronal networks—primarily involving cortical motor tracts (e.g., corticospinal tract), spinal motor neurons, interneurons, and their synaptic connections—that regulate voluntary and reflexive muscle activity. Dysfunction or excessive excitation of these pathways, such as from loss of inhibitory input, disruption of ion channel function, or altered neurotransmitter signaling, can result in pathological muscle spasms, cramps, or spasticity. Several classes of medications (like baclofen, tizanidine, and quinine) interact with various molecular components within these pathways to reduce abnormal muscle contraction, but the "central nervous system muscle spasm pathways" is not a single molecule, receptor, or druggable target. Rather, it is a systems-level concept encompassing numerous molecular targets including GABAergic receptors, presynaptic and postsynaptic ion channels, and neuromodulatory pathways in the CNS[1][2][3][5][6].

Other names

CNS spasm circuitsCentral pathways for muscle spasmMotor neuron spasm pathways

Modulation of inhibitory neurotransmission (e.g., GABA-B agonism by baclofen) Inhibition of spinal motor neuron excitability Blockade of sodium and potassium channels